X-Chem

NEWS

Lone Star Bio

What It’s Like To Be A Principal Research Scientist At X-Chem

November 2, 2016

·

1 min read

IN THE PRESS

Business

X-Chem And MD Anderson Cancer Center Enter Partnership To Discover Novel, Small Molecule Therapies For Cancer

January 6, 2016

·

4 min read

Business

X-Chem And Navitor Pharmaceuticals Enter Into License Agreement On Novel Small Molecules Targeting mTORC1 Activation

March 31, 2015

·

1 min read

Business

X-Chem Announces Collaboration With Janssen Pharmaceutical Inc. And Johnson & Johnson Innovation Innovation To Advance Novel Candidates To Treat Inflammatory Diseases

January 9, 2015

·

6 min read

Business

X-Chem Promotes Diala Ezzeddine To Executive Vice President And Chief Business Officer

January 9, 2015

·

1 min read

Business

X-Chem Licenses Cardiovascular Drug Discovery Program To Bayer Pharma AG

December 17, 2014

·

6 min read

Business

X-Chem And Alexion Pharmaceuticals Inc. Collaborate To Discover Novel Therapeutic Candidates To Treat Patients With Severe And Ultra-Rare Disorders

December 11, 2014

·

6 min read

Deals

PPD, Inc. Exercises Option To Acquire Remaining Interest In X-Chem

September 25, 2014

·

1 min read

Business

X-Chem Enters Into Multi-Target Collaboration With Pfizer Inc.

June 11, 2014

·

1 min read

Business

X-Chem Licenses Epigenetic Drug Discovery Program To Bayer Pharma AG

February 13, 2014

·

1 min read

Genetown

X-Chem First Biotech To Exceed 100 Billion Compounds With Its Unique And Proprietary Small Molecule DNA-Encoded Library

February 4, 2014

·

1 min read

JOBS